PDI expecting cuts from AstraZeneca: Reuters

Sales and marketing services provider PDI expects significant reductions in the 800 sales reps it contracts with AstraZeneca, according to a Reuters report. The reductions came as part of discussions with AstraZeneca over the status of fees for service contract sales engagements. AstraZeneca said it would comment further once it has more information about the scope and timing of the changes, the report said.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions